instit.oncol.cluj-napoca- sectia hematologie - 2012
instit.oncol.cluj-napoca- sectia hematologie - 2012
instit.oncol.cluj-napoca- sectia hematologie - 2012
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
- Prednison 1mg/kg zilele 1-5<br />
- Ciclurile se repetă la 3 săptămâni, 8 cicluri<br />
8. Cladribina :<br />
- 0,14 mg/kg zilele 1-5, se repeta la 4 saptamani<br />
9. Bendamustina-Rituximab<br />
- Bendamustin 70 mg/m 2 zilele 1si 2<br />
- Rituximab 375mg/m 2 in ziua 0 la primul ciclu, apoi 500 mg/m 2 la ciclurile<br />
urmatoare<br />
Ciclurile se repeta la 28 de zile, 6 cicluri<br />
BIBLIOGRAFIE<br />
1.Tam CS, O’Brien S, Wierda W et al. Long-term results of the fludarabine, cyclophosphamide,<br />
and rituximab regimen as initial therapy of chronic lymphocytic leukemia, blood 2008 ;112 :975-<br />
980<br />
2.Eichhorst BF, Busch R, Stillgenbauer s et al.First-line therapy with fludarabine compared with<br />
chlorambucil does not result in a major benefit for elderly patients with advanced chronic<br />
lymphocytic leukemia.Blood 2009 ;114 :3382-3391<br />
3.Hillmen P, Skotnicki AB, Robak T, et al.Alemtuzumab compared with chlorambucil as first-line<br />
chemotherapy for chronic lumphocytic leukemia.J.Clin.Oncol 2007 ;25 :5616-5623<br />
4.Knauf WU, Lissichkov T, Aldaoud A et al.Phase III randomised study of bendamustine<br />
compared with chlorambucil in previously untrated patients with chronic lymphocytic leukemia.J<br />
ClinOncol 2009 ;27 :4378-4384<br />
5. Hillmen P. Chronic lymphocytic leukemia. Standard and novel treatments in first line and in<br />
relapse/refractory situation. Hematology Education, 17 th Congress of EHA, 93-100